Literature DB >> 2496916

Possible involvement of Ca2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma cells.

B Korczak1, C Whale, R S Kerbel.   

Abstract

Evidence is provided to show that two secondary cell-signaling pathways, Ca2+ mobilization and the activation of protein kinase C (PKC), are involved in the induction of spontaneous metastasis in mouse adenocarcinoma cell line SP1. Unlike the parental cells, which were found to be tumorigenic but unable to metastasize from a s.c. site, SP1 cells treated with ionophore A23187 (to mobilize Ca2+) or phorbol 12-myristate 13-acetate (to activate PKC) were able to metastasize spontaneously. Analysis of SP1 cells treated with either agent separately or with both agents simultaneously revealed that both pathways contributed to the final response in a separate and nonsynergistic way. The induced metastatic phenotype in most cases appeared to be heritable. Examination of Ca2+ sources during cell activation by ionophore A23187 suggested that internal Ca2+ was sufficient for the process of induction. Examination of PKC activity and its intracellular distribution during and after treatment of SP1 cells with ionophore A23187 and phorbol 12-myristate 13-acetate were also evaluated. The results suggested that the basal levels of PKC and the activation of the enzyme appear to be involved in the induction of spontaneous metastasis. Taken together, these observations are consistent with the hypothesis that cell-signaling pathways exist which can induce the metastatic phenotype and that this may be related to phosphatidylinositol turnover.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496916

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.

Authors:  B Schlatter; C G Waghorne
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 2.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

3.  Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

Authors:  J H Uhm; N P Dooley; J G Villemure; V W Yong
Journal:  Clin Exp Metastasis       Date:  1996-10       Impact factor: 5.150

4.  Acidic pH enhances the invasive behavior of human melanoma cells.

Authors:  R Martínez-Zaguilán; E A Seftor; R E Seftor; Y W Chu; R J Gillies; M J Hendrix
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

Review 5.  The role of endothelial cells in tumor invasion and metastasis.

Authors:  N Jahroudi; J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 6.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

7.  Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells.

Authors:  R Gopalakrishna; Z H Chen; U Gundimeda
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 8.  Regulation of protein kinase C and role in cancer biology.

Authors:  G C Blobe; L M Obeid; Y A Hannun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

9.  Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C.

Authors:  B Liu; J Timar; J Howlett; C A Diglio; K V Honn
Journal:  Cell Regul       Date:  1991-12

10.  Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma.

Authors:  S D Pencil; Y Toh; G L Nicolson
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.